1 in 8 adults has taken Ozempic or other GLP-1 drug: Survey
A new poll from the health policy nonprofit KFF found that one in eight adults say they've taken a GLP-1 agonist, the obesity and diabetes medications that include Ozempic, Mounjaro and Zepbound.
Among those surveyed, 12 percent said they had used a GLP-1 agonist, with six percent saying they're currently using one. The majority — 62 percent — said they were using the drugs to treat a chronic condition like diabetes or heart disease while the remaining 38 percent they took the medications just to lose weight.
Nearly half of the participants with diabetes — four out of 10 — said they had used a GLP-1 agonist.
GLP-1 agonists are indicated for treating people who have diabetes, obesity or are at risk of cardiovascular disease related incidents. The drugs' off-label use for cosmetic weight loss has sparked widespread interest.
Awareness of these drugs seemed to be relatively high, with a third saying they'd heard "a lot" about the medications and 27 percent saying they'd heard "some." Older, wealthier adults and those with chronic illnesses were more likely to have heard something about GLP-1 agonists.
About 80 percent said they got a GLP-1 agonist through their primary care provider or a specialist. Another 23 percent said they got the drugs from either an online provider, a medical spa or "somewhere else."
Several GLP-1 agonists like Ozempic, Mounjaro and Trulicity are currently in shortage, with the Food and Drug Administration reporting the reason as an increase in demand.
Survey participants were also asked whether they believed Medicare should cover GLP-1 agonists. The federal healthcare program is barred from covering weight loss medications, though the recent approval of the weight loss drug Wegovy for cardiovascular disease now means Medicare beneficiaries can access the drug.
A previous KFF analysis indicated that as many as one in four beneficiaries who have obesity could get Weogvy following its expanded approval.
In total, 61 percent said Medicare should cover GLP-1 agonists to treat obesity. Their opinions remained effectively unchanged after being told the arguments Medicare against covering obesity medications, such as the possibility that premiums could go up coverage would place financial strain on the government program.
The KFF survey was conducted between April 23 and May 1, including a sample of 1,479 U.S. adults.
Date: |
Filter
-
Hims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warnings
Hims & Hers Health’s stock jumped more than 30% Monday morning after the health and wellness platform said it would offer compounded versions of popular GLP-1 drugs.MarketWatch - Business -
Hims & Hers to sell GLP-1 weight loss drug for 85% less than Wegovy
Hims & Hers is pitching consumers on a GLP-1 weight loss injection that will cost 85% less than brand-name drugs like Wegovy.CBS News - Top stories -
1 in 3 Black Americans says integration hasn't helped Black students: Survey
Seventy years after the landmark Supreme Court decision to end segregation in schools, a majority of Americans believe more should be done to racially integrate schools. A new Washington Post-Ipsos survey found that 86 percent of U.S. adults ...The Hill - Politics -
Hims & Hers Health says it will offer compounded GLP-1 injections
Hims & Hers Health is introducing access to compounded GLP-1 weight loss injections as Ozempic and Wegovy soar in popularity.NBC News - Top stories -
Loperfido hits first MLB homer, Javier solid as Astros beat A's 8-1 to complete sweep
Rookie Joey Loperfido hit his first major league home run and Cristian Javier pitched six scoreless innings Thursday night to help the Houston Astros beat the Oakland Athletics 8-1 and complete a four-game sweepABC News - Sports - MLB -
Indian authorities seize over $1 billion worth of illegal vote inducements, including drugs and cash, in country's elections
Yahoo News - World -
Shares of Hims & Hers Health surge 27% after startup says it will offer GLP-1 injections
The GLP-1 market has faced supply constraints in recent months as drugs like Ozempic and Wegovy continue to skyrocket in popularity.CNBC - Business -
NFL 2024 rookie QB outlook: Best- and worst-case scenarios for Caleb Williams, other Year 1 signal-callers
How good (or bad) could it get for the newest crop of passers in 2024?CBS Sports - Sports - NFL -
1 person has died and another is hurt after a fiery tanker truck crash in Colorado
One person is dead and another has been hospitalized after a vehicle crashed into a tanker truck carrying fuel on Colorado’s main east-west highwayABC News - Top stories -
Brady Tkachuk has goal, 3 assists in US 4-1 win over Poland at men's hockey world championship
Brady Tkachuk scored a goal and added three assists and the United States clinched a playoff-round berth with a 4-1 win over Poland in preliminary round play at the men’s world hockey championshipsABC News - Sports - NHL
More from The Hill
-
Colorado tackles discrimination in AI
Welcome to The Hill's Technology newsletter {beacon} Technology Technology The Big Story Colorado governor signs AI law Colorado will require developers of artificial intelligence (AI) to avoid discrimination in high-risk systems as part of a ...The Hill - Politics -
What is the ICC?
The International Criminal Court (ICC) was in the global spotlight Monday after its prosecutor requested arrest warrants for two Hamas leaders, along with Israeli Prime Minister Benjamin Netanyahu and his defense minister, claiming the court has ...The Hill - Politics -
US lashes out after Israeli officials targeted with arrest warrants
U.S. officials went on the offensive Monday after the International Criminal Court (ICC) filed arrest warrants against two top Israeli leaders over the war in Gaza, a move that Congress and the White House slammed for equating Israel's conduct ...The Hill - Politics - Israel -
Evening Report — Prosecution rests after tough day on the stand for Michael Cohen
A quick recap of the day and what to look forward to tomorrow {beacon} Evening Report Monday, May 20 © Angela Weiss/Pool Photo via AP/Andres Kudacki Prosecution rests after a tough day on the stand for Michael Cohen Prosecutors for the ...The Hill - Politics -
FDIC chair says he'll resign once successor is confirmed
Federal Deposit Insurance Corp. (FDIC) Chair Martin Gruenberg announced Monday he will resign once his successor is confirmed by the Senate after several reports documented a culture of sexual harassment, misconduct and retaliation at the agency ...The Hill - Politics